- $2.67m
- -$9.92m
- $42.30m
- 53
- 100
- 1
- 50
Annual income statement for C3is, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 20-F | 6-K |
| Standards: | USG | USG | — |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 16.1 | 28.7 | 42.3 |
| Cost of Revenue | |||
| Gross Profit | 10.3 | 16.1 | 19.8 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Total Operating Expenses | -2 | 18.3 | 32.2 |
| Operating Profit | 18.1 | 10.4 | 10.1 |
| Total Net Non Operating Interest Income / Expense | |||
| Net Income Before Taxes | 18 | 9.29 | -2.75 |
| Net Income After Taxes | 18 | 9.29 | -2.75 |
| Net Income Before Extraordinary Items | |||
| Net Income | 18 | 9.29 | -2.75 |
| Adjustments to Net Income | |||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 18 | 8.53 | -8.09 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 357 | 875 | -4.29 |